Industry Webcast
Albuminuria and Cardiovascular Risk: The Power of Early Detection and CKD DiagnosisIndustry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Not for CME/CE Credit
This presentation will highlight the role of albuminuria as a sign of vascular damage in the cardiorenal system and as a strong, independent predictor of cardiovascular risk. It will equip attendees with practical strategies and guideline recommendations for implementing UACR testing to proactively identify CKD and manage hidden cardiovascular risk in patients.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 10/15/2025
Expiration Date: 10/15/2025
Topics
Faculty
Faculty
Supporters and Partners
Industry Sponsor
Boehringer Ingelheim Pharmaceuticals, Inc.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.